methylselenic acid has been researched along with Breast Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fesenko, EE; Goltyaev, MV; Varlamova, EG | 1 |
| Sundaram, S; Yan, L | 1 |
| Deng, G; Jiang, K; Qiu, C; Qiu, J; Wu, H; Zhang, T; Zhao, G; Zhu, X | 1 |
| Chen, C; Li, F; Liu, H; Yao, Q; Younes, M; Zhang, S | 1 |
| Andrade, Fde O; Conti, Ad; Dagli, ML; de Miranda, JX; Moreno, FS; Ong, TP | 1 |
| Chen, PC; Guo, CH; Hsia, S; Hsieh, FC; Shih, MY | 1 |
| Carrier, L; Li, Z; Rowan, BG | 1 |
| Chen, YC; Gandhi, UH; Mastro, AM; Novinger, LJ; Prabhu, KS; Sosnoski, DM | 1 |
| Dong, Y; Edwards, DP; Gao, R; Liu, X; Nishi, Y; Rowan, BG; Wabitsch, M; Yanase, T; Yu, Q; Zhao, L | 1 |
| Dong, Y; Fu, X; Hill, SM; Qi, Y; Rowan, BG; Xiong, Z; Zhang, H | 1 |
| Chen, S; Chen, Y; Lin, D; Ma, RZ; Pei, Z; Wu, X; Yang, X; Zhang, Y | 1 |
| Dong, Y; Fan, L; Guo, X; Hu, H; Lu, J; Ye, M; Yin, S | 1 |
| Miura, K; Nakamuro, K; Okuno, T; Sakazaki, F; Ueno, H | 1 |
| Dong, Y; Gao, AC; Ip, C; Lee, SO; Lou, W; Nadiminty, N; Onate, SA; Wu, XX | 1 |
| Al-Dhaheri, M; Dong, Y; Ip, C; Jones, FE; Rowan, BG; Shah, YM | 1 |
| Dong, Y; Ip, C; Kaul, A; Rowan, BG; Shah, YM | 1 |
| Jia, L; Kline, K; Sanders, BG; Snyder, RM; Yu, W | 1 |
| Dong, Y; Ganther, HE; Ip, C; Stewart, C | 1 |
18 other study(ies) available for methylselenic acid and Breast Neoplasms
| Article | Year |
|---|---|
Protein Partners of Selenoprotein SELM and the Role of Selenium Compounds in Regulation of Its Expression in Human Cancer Cells.
Topics: Adenocarcinoma; Breast Neoplasms; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Neoplasm Proteins; Organoselenium Compounds; Selenoproteins | 2019 |
Dietary Supplementation with Methylseleninic Acid Inhibits Mammary Tumorigenesis and Metastasis in Male MMTV-PyMT Mice.
Topics: Adiponectin; Animals; Biomarkers; Breast Neoplasms; Cell Transformation, Neoplastic; Dietary Supplements; Female; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Organoselenium Compounds | 2018 |
Methylseleninic Acid Suppresses Breast Cancer Growth via the JAK2/STAT3 Pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Janus Kinase 2; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Organoselenium Compounds; Signal Transduction; STAT3 Transcription Factor | 2019 |
Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Staging; Organoselenium Compounds; Receptors, Estrogen; Receptors, Progesterone; Selenium; Selenium-Binding Proteins; Survival Analysis; Tumor Suppressor Protein p53 | 2013 |
Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Proliferation; Epigenesis, Genetic; Female; Humans; MCF-7 Cells; Organoselenium Compounds; Selenious Acid; Selenium Compounds; Tumor Suppressor Proteins | 2014 |
Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Glutathione Peroxidase; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Organoselenium Compounds; Oxidative Stress; Reactive Oxygen Species; Selenium; Selenocysteine; Superoxide Dismutase; Yeasts | 2015 |
Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Blotting, Western; Breast Neoplasms; Caspase 8; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Female; G1 Phase; Humans; Membrane Proteins; Mitochondria; Models, Biological; Organoselenium Compounds; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Tamoxifen | 2008 |
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Communication; Cell Differentiation; Cell Line, Tumor; Chemokine CCL2; Culture Media, Conditioned; Cyclooxygenase 2; Female; Humans; Inflammation; Interleukin-6; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Organoselenium Compounds; Osteoblasts; Selenium | 2009 |
Methylseleninic acid is a novel suppressor of aromatase expression.
Topics: Adenylyl Cyclases; Adipocytes; Antineoplastic Agents, Hormonal; Aromatase; Breast Neoplasms; Cell Line; Cell Line, Tumor; Colforsin; Dexamethasone; Down-Regulation; Enzyme Activators; Enzyme Induction; Female; Glucocorticoids; Humans; Neoplasm Proteins; Organoselenium Compounds; Ovarian Neoplasms; Ovary; Promoter Regions, Genetic; Recombinant Proteins; RNA, Messenger | 2012 |
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice; Organoselenium Compounds; Paclitaxel; Xenograft Model Antitumor Assays | 2012 |
Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2.
Topics: Angiopoietin-2; Animals; Blotting, Western; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Female; Gene Expression; Humans; Immunohistochemistry; Mice; Mice, Nude; Organoselenium Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: potential role of Mcl-1 and FAK.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Inducing Factor; Breast Neoplasms; Cell Line, Tumor; Curcumin; Female; Focal Adhesion Kinase 1; Humans; Male; Myeloid Cell Leukemia Sequence 1 Protein; Organoselenium Compounds; Prostatic Neoplasms; Reactive Oxygen Species; Up-Regulation | 2013 |
Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system.
Topics: Antineoplastic Agents; Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Organoselenium Compounds; Oxidative Stress; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Thioredoxin-Disulfide Reductase; Thioredoxins; Transcription Factors; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2012 |
Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Ligands; Organoselenium Compounds; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction | 2005 |
Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Endometrial Neoplasms; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Humans; Neoplasms, Hormone-Dependent; Organoselenium Compounds; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 2005 |
Attenuation of estrogen receptor alpha (ERalpha) signaling by selenium in breast cancer cells via downregulation of ERalpha gene expression.
Topics: Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Organoselenium Compounds; Signal Transduction | 2005 |
Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Resveratrol; Stilbenes; Tocopherols; Vitamin E | 2008 |
Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays.
Topics: Anticarcinogenic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Cycle; Cells, Cultured; G1 Phase; Gene Expression; Growth Inhibitors; Humans; Oligonucleotide Array Sequence Analysis; Organoselenium Compounds; Resting Phase, Cell Cycle | 2002 |